FrancophonIA/ELRC3.0 huggingface dataset:
English: The following guidance is based on the half-life of darunavir in the presence of cobicistat or ritonavir and the recommended dosing interval of approximately 12 hours (twice daily regimen) or approximately 24 hours (once daily regimen).
Slovenian: Navodilo temelji na razpolovnem času darunavirja v prisotnosti kobicistata ali ritonavirja in priporočenem režimu odmerjanja na približno 12 ur (odmerjanje dvakrat na dan) ali na približno 24ur (odmerjanje enkrat na dan).
English: TLOVR non-VF censored algorithm based on HIV-1 RNA < 50 copies/ml, except for TITAN (HIV-1 RNA < 400 copies/ml) IAS-USA lists
Slovenian: TLOVR ne-VF cenzoriran algoritem, na osnoviHIV-1 RNK < 50 kopij/ml, razen za preskušanje TITAN (HIV-1 RNK < 400 kopij/ml)
English: The use of only 75 mg and 150 mg tablets or the 100 mg/ml oral suspension to achieve the recommended dose of PREZISTA could be appropriate when there is a possibility of hypersensitivity to specific colouring agents.
Slovenian: Uporaba samo 75 mg in 150 mg tablet ali 100 mg/ml peroralne suspenzije za doseganje priporočenega odmerka zdravila PREZISTA je upravičena, kadar obstaja verjetnost za pojav preobčutljivosti za barvilo.
English: PREZISTA 75 mg, 150 mg, 300 mg, and 600 mg tablets may be used to provide suitable dose regimens (see section 4.2):
Slovenian: PREZISTA 75 mg, 150 mg, 300 mg in 600 mg tablete se lahko uporabljajo za zagotavljanje ustreznega odmerjanja (glejte poglavje 4.2):
English: BOTTLE LABEL FOR ORAL SUSPENSION
Slovenian: NALEPKA NA VSEBNIKU ZA PERORALNO SUSPENZIJO
English: The lowest rates of developing resistant HIV virus are observed in ART-naïve patients who are treated for the first time with darunavir in combination with other ART.
Slovenian: Najnižjo stopnjo razvoja odpornih HIV virusov so opazili pri bolnikih, ki niso imeli izkušenj z ART in so jih prvič zdravili z darunavirjem v kombinaciji z drugimi protiretrovirusnimi zdravili.
English: PREZISTA in combination with cobicistat or ritonavir has no or negligible influence on the ability to drive and use machines.
Slovenian: V kombinaciji s kobicistatom ali z ritonavirjem, zdravilo PREZISTA nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
English: Ritonavir may decrease plasma concentrations of voriconazole.
Slovenian: Ritonavir, lahko zniža plazemske koncentracije vorikonazola.
English: Darunavir/ritonavir (600/100 mg twice daily or 800/100 mg once daily) in combination with a background regimen was evaluated in a clinical trial of 36 pregnant women (18 in each arm) during the second and third trimesters, and postpartum.
Slovenian: Darunavir/ritonavir (600/100 mg dvakrat na dan ali 800/100 mg enkrat na dan) v kombinaciji z osnovno shemo so ocenjevali v kliničnem preskušanju pri 36 nosečnicah (18 v vsaki skupini) med drugim in tretjim trimesečjem nosečnosti ter v obdobju po porodu.
English: Imputations according to the TLOVR algorithm Based on a normal approximation of the difference in % response Clades A1, D, F1, G, K, CRF02_AG, CRF12_BF, and CRF06_CPX Difference in means
Slovenian: Pod-tipi A1, D, F1, G, K, CRF02_AG, CRF12_BF in CRF06_CPX razlika povprečnih vrednosti
English: The dose of cobicistat to be used with PREZISTA has not been established in this patient population.
Slovenian: Odmerka kobicistata za uporabo z zdravilom PREZISTA pri tej populaciji niso določili.
English: Open the bottle of PREZISTA oral suspension by pushing downward on the cap and twisting it counter-clockwise.
Slovenian: Steklenico zdravila PREZISTA peroralna suspenzija odprite tako, da zaporko potisnete navzdol in jo pri tem obračajte v nasprotni smeri urinega kazalca.
English: Cobicistat has not been studied in patients receiving dialysis, and, therefore, no recommendation can be made for the use of darunavir/cobicistat in these patients.
Slovenian: Pri bolnikih, ki se zdravijo z dializo, kobicistata niso preučevali, zato priporočil za uporabo zdravil darunavir/kobicistat pri teh bolnikih ni mogoče podati.
English: Didanosine is to be administered on an empty stomach, thus it should be administered 1 hour before or 2 hours after boosted PREZISTA given with food.
Slovenian: Didanozin je treba jemati na tešče, zato ga je potrebno zaužiti 1 uro pred ali 2 uri po odmerjanju okrepljenega zdravila PREZISTA in hrane.
English: If you take PREZISTA once a day and if you notice within 12 hours, you must take the oral suspension immediately.
Slovenian: Če jemljete zdravilo PREZISTA enkrat na dan in to opazite v 12 urah, morate vzeti peroralno suspenzijo takoj.
English: The recommended dose of PREZISTA with low dose ritonavir should not exceed the recommended adult dose (600/100 mg twice daily or 800/100 mg once daily).
Slovenian: Priporočeni odmerek zdravila PREZISTA skupaj z majhnim odmerkom ritonavirja ne sme preseči priporočenega odmerka za odrasle (600/100 mg dvakrat na dan ali 800/100 mg enkrat na dan).
English: PREZISTA 100 mg/ml oral suspension
Slovenian: PREZISTA 100 mg/ml peroralna suspenzija
English: During the clinical development program (N=2,613 treatment-experienced subjects who initiated therapy with PREZISTA/ritonavir 600/100 mg twice daily), 51.3% of subjects experienced at least one adverse reaction.
Slovenian: Med kliničnim preskušanjem zdravila (n=2.613 preiskovancev, z izkušnjami s protiretrovirusno terapijo, ki so se začeli zdraviti z zdraviloma PREZISTA/ritonavir 600/100 mg dvakrat na dan) se je pri 51,3% preiskovancev pojavil najmanj en neželen učinek.
English: PREZISTA co-administered with low dose ritonavir should be used during pregnancy only if the potential benefit justifies the potential risk.
Slovenian: Zdravilo PREZISTA z majhnim odmerkom ritonavirja smemo uporabljati med nosečnostjo le, če morebitna korist odtehta možno tveganje.
English: Co-administration with PREZISTA/ritonavir may cause a large increase in the concentration of these medicines.
Slovenian: Sočasna uporaba s kombinacijo PREZISTA/ritonavir lahko povzroči veliko zvišanje koncentracij teh zdravil.
English: PREZISTA oral suspension contains sodium methyl parahydroxybenzoate (E219) which may cause allergic reactions (possibly delayed).
Slovenian: Zdravilo PREZISTA peroralna suspenzija vsebuje natrijev metilparahidroksibenzoat (E219), ki lahko povzroči alergijske reakcije (reakcija je lahko zapoznela).
English: Dose for adults who have not taken antiretroviral medicines before (your doctor will determine this)
Slovenian: Odmerek za odrasle, ki še niste prejemali protiretrovirusnega zdravljenja (to bo določil vaš zdravnik)
English: Limited information is available in this population, and therefore, PREZISTA should be used with caution in this age group (see sections 4.4 and 5.2).
Slovenian: Podatki, pri tej populaciji so omejeni, zato je pri uporabi zdravila PREZISTA v tej skupini potrebna previdnost (glejte poglavji 4.4 in 5.2).
English: The use of 75 mg and 150 mg tablets to achieve the recommended dose is appropriate when there is a possibility of hypersensitivity to specific colouring agents, or difficulty in swallowing the 300 mg or 600 mg tablets.
Slovenian: Uporaba 75 mg in 150 mg tablet za doseganje priporočenega odmerka je primerna kadar obstaja možnost preobčutljivosti na barvila v 300 mg ali 600 mg tabletah ali če jih bolnik ne more pogoltniti.
English: Voriconazole should not be combined with PREZISTA co-administered with low dose ritonavir unless an assessment of the benefit/risk ratio justifies the use of voriconazole.
Slovenian: Vorikonazola se ne sme sočasno uporabljati z zdravilom PREZISTA z majhnim odmerkom ritonavirja razen, če ocena razmerja med koristmi in tveganjem opravičuje uporabo vorikonazola.
English: - Tell your doctor if you are allergic to sulphonamides (e.g. used to treat certain infections).
Slovenian: - Povejte svojemu zdravniku, če ste preobčutljivi (alergični) na sulfonamide (zdravila za zdravljenje določenih okužb).
English: based on published data with darunavir/ritonavir
Slovenian: na osnovi objavljenih podatkovs kombinacijo darunavir/ritonavir
English: Interactions between PREZISTA/ritonavir and antiretroviral and non-antiretroviral medicinal products are listed in the table below.
Slovenian: Interakcije med darunavirjem/ritonavirjem in drugimi protiretrovirusnimi in ne-protiretrovirusnimi zdravili so navedene v spodnji preglednici.
English: Shake bottle vigorously before use.
Slovenian: Pred uporabo steklenico močno pretresite.
English: The weight-based dose of PREZISTA and ritonavir in paediatric patients is provided in the table below.
Slovenian: Odmerek zdravil PREZISTA in ritonavirja glede na telesno maso pri pediatričnih bolnikih je naveden v spodnji preglednici.
English: Didanosine is to be administered on an empty stomach, thus it should be administered 1 hour before or 2 hours after PREZISTA/ritonavir given with food.
Slovenian: Didanozin je treba jemati na tešče, zato, ga je potrebno zaužiti 1 uro pred ali 2 uri po aplikaciji zdravil PREZISTA/ritonavir in hrane.
English: Remove the unscrewed cap.
Slovenian: Snemite odvito zaporko.
English: Ritonavir inhibits the transporters P-glycoprotein, OATP1B1 and OATP1B3, and co-administration with substrates of these transporters can result in increased plasma concentrations of these compounds (e.g. dabigatran etexilate, digoxin, statins and bosentan; see the Interaction table below).
Slovenian: Ritonavir zavira prenašalce P-gp, OATP1B1 in OATP1B3, zato lahko sočasna uporaba s substrati teh prenašalcev poviša njihove plazemske koncentracije (npr. dabigatraneteksilat, digoksin, statini in bosentan; glejte preglednico medsebojnih delovanj z drugimi zdravili).
English: Remove the plunger from the barrel of the pipette, rinse both with water and allow to air dry after each use.
Slovenian: Po vsaki uporabi odstranite bat iz odmerne kapalke, sperite oba dela kapalke z vodo in ju posušite na zraku.
English: The child must take PREZISTA every day and always in combination with 100 milligram of ritonavir and with food.
Slovenian: Otrok mora zaužiti zdravilo PREZISTA vsak dan in vedno skupaj s 100 mg ritonavirja in s hrano.
English: DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) and Stevens-Johnson Syndrome has been rarely (< 0.1%) reported, and during post-marketing experience toxic epidermal necrolysis and acute generalised exanthematous pustulosis have been reported.
Slovenian: DRESS (Drug Rash with Eosinophilia and Systemic Symptoms-kožni izpuščaj z eozinofilijo in sistemskimi simptomi) in Stevens-Johnsonov sindrom sta se pojavila redko (< 0,1%).
English: Viruses isolated from patients on PREZISTA/ritonavir 600/100 mg twice daily experiencing virologic failure by rebound that were susceptible to tipranavir at baseline remained susceptible to tipranavir after treatment in the vast majority of cases.
Slovenian: Virusi, izolirani pri bolnikih, ki so prejemali zdravilo PREZISTA/ritonavir 600/100 mg dvakrat na dan, pri katerih je prišlo do virološke odpovedi in so bili na začetku preskušanj občutljivi za tipranavir so v veliki večini primerov ostali občutljivi za tipranavir tudi po zdravljenju.
English: In a multiple dose study with PREZISTA co-administered with ritonavir (600/100 mg) twice daily, it was demonstrated that the total plasma concentrations of darunavir in subjects with mild (Child-Pugh Class A, n=8) and moderate (Child-Pugh Class B, n=8) hepatic impairment were comparable with those in healthy subjects.
Slovenian: Preskušanje večkratnega odmerjanja zdravila PREZISTA z ritonavirjem (600/100 mg dvakrat na dan), je pokazalo, da so bile celokupne plazemske koncentracije darunavirja pri posameznikih z blago (razred A po Child-Pughovi lestvici, n=8) in srednje hudo (razred B po Child-Pughovi lestvici, n=8) jetrno okvaro primerljive s tistimi pri zdravih posameznikih.
English: If alternatives cannot be used, its use should only take place after medical evaluation and under close monitoring by your doctor for corticosteroid side effects.
Slovenian: Kadar ni možno uporabiti drugih zdravil, se lahko uporabljajo le po zdravniškem pregledu in ob natančnem zdravniškem spremljanju zaradi možnosti pojava neželenih učinkov, povezanih s kortikosteroidov.
English: What PREZISTA contains - The active substance is darunavir.
Slovenian: Kaj vsebuje zdravilo PREZISTA - Učinkovina je darunavir.
English: In addition, patients on a stable dose of these antidepressants who start treatment with boosted PREZISTA should be monitored for antidepressant response.
Slovenian: Pri bolnikih na stabilnem odmerku teh antidepresivov, ki začenjajo zdravljenje z okrepljenim zdravilom PREZISTA, je treba spremljati učinek zdravljenja z antidepresivom.
English: • For the treatment of HIV-1 infection in paediatric patients from the age of 3 years and at least
Slovenian: • za zdravljenje okužbe s HIV-1 pri pediatričnih bolnikih, starih najmanj 3 leta in s telesno maso najmanj 15 kg.
English: As limited information is available on the use of PREZISTA in patients aged 65 and over, caution should be exercised in the administration of PREZISTA in elderly patients, reflecting the greater frequency of decreased hepatic function and of concomitant disease or other therapy (see sections 4.2 and 5.2).
Slovenian: Ker so podatki o uporabi zdravila PREZISTA pri bolnikih starih 65 let ali več omejeni, je pri teh bolnikih potrebna previdnost, saj je pri njih pogosteje prisotno zmanjšanje jetrne funkcije, imajo pogosteje še druge sočasne bolezni in pogosteje potrebujejo še druga zdravila (glejte poglavji 4.2 in 5.2).
English: Therefore, PREZISTA must not be used in patients with severe hepatic impairment (Child-Pugh Class C) (see sections 4.3, 4.4 and 5.2).
Slovenian: Zato se zdravila PREZISTA pri bolnikih s hudo okvaro jeter (razred C po Child-Pughovi lestvici) ne sme uporabljati (glejte poglavja 4.3, 4.4 in 5.2).
English: Pravastatin 40 mg single dose pravastatin AUC ↑ 81% pravastatin Cmin ND pravastatin Cmax ↑ 63%
Slovenian: pravastatin enkratni odmerek 40 mg pravastatin AUC ↑ 81% pravastatin Cmin ND pravastatin Cmax ↑ 63%
English: β-BLOCKERS Carvedilol Metoprolol Timolol
Slovenian: karvedilol metoprolol timolol
English: The combination of PREZISTA and artemether/lumefantrine can be used without dose adjustments; however, due to the increase in lumefantrine exposure, the combination should be used with caution.
Slovenian: Kombinacija zdravil PREZISTA in učinkovin artemeter/lumefantrin se lahko uporablja brez prilagajanja odmerkov, vendar je zaradi zvečane izpostavljenosti lumefantrinu, pri tej kombinaciji potrebna previdnost.
English: Appropriate laboratory testing should be conducted prior to initiating therapy with PREZISTA/ritonavir and patients should be monitored during treatment.
Slovenian: Pred začetkom zdravljenja z zdraviloma PREZISTA/ritonavir je treba opraviti ustrezne laboratorijske teste in spremljati bolnika med zdravljenjem.
English: 600 milligram PREZISTA + 100 milligram ritonavir twice a day * For children aged 12 or more and weighing at least 40 kilograms, your child's doctor will determine if PREZISTA
Slovenian: 600 miligramov zdravila PREZISTA + 100 miligramov ritonavirja dvakrat na dan * Za otroke, stare 12 let ali starejše in s telesno maso najmanj 40 kg bo zdravnik določil ali lahko uporabljajo
English: The PREZISTA 800 milligram tablets are available in packs containing one bottle or three bottles per carton.
Slovenian: Zdravilo PREZISTA 800 mg filmsko obložene tablete je na voljo v škatlah, ki vsebujejo 1 ali 3 plastenke.
English: Pack includes a 6 ml dosing pipette with 0.2 ml gradations.
Slovenian: Pakiranje vsebuje 6 ml odmerno kapalko z umeritvenimi oznakami vsakih 0,2 ml
English: - The other ingredients are hydroxypropylcellulose, microcrystalline cellulose and carmellose sodium, citric acid monohydrate, sucralose, strawberry cream flavour, masking flavour, sodium methyl parahydroxybenzoate (E219), hydrocholoric acid (for pH adjustment), purified water.
Slovenian: - Druge sestavine zdravila so hidroksipropilceluloza, mikrokristalna celuloza, natrijev karmelozat, citronska kislina monohidrat, sukraloza, okus jagodne kreme, prekrivni okus, natrijev metilparahidroksibenzoat (E219), klorovodikova kislina (za uravnavanje pH), prečiščena voda.
English: Tell your doctor if you take: - Phenobarbital, phenytoin (to prevent seizures) - Dexamethasone (corticosteroid) - Efavirenz (HIV infection) - Boceprevir (hepatitis C infection) - Rifapentine, rifabutin (medicines to treat some infections such as tuberculosis) - Saquinavir (HIV infection).
Slovenian: Povejte svojemu zdravniku, če jemljete: - fenobarbital, fenitoin (za preprečevanje epileptičnih napadov) - deksametazon (kortikosteroid) - efavirenz (za zdravljenje okužbe s HIV) - boceprevir (za zdravljenje okužbe z virusom hepatitisa C) - rifapentin, rifabutin (zdravili za zdravljenje nekaterih okužb kot je tuberkuloza) - sakvinavir (za zdravljenje okužbe s HIV)
English: Instructions for children - The child must take PREZISTA always together with ritonavir.
Slovenian: Navodila za otroke - Otrok mora zdravilo PREZISTA vedno zaužiti skupaj z ritonavirjem.
English: Viruses selected in these conditions and showing decreased susceptibility to darunavir (range: 23-50-fold) harboured 2 to 4 amino acid substitutions in the protease gene.
Slovenian: Selekcionirani virusi niso mogli rasti pri koncentracijah darunavirja nad 400 nM. Virusi, selekcionirani v teh pogojih, z zmanjšano občutljivostjo na darunavir (razpon: 23 do 50-krat), so imeli 2 do 4 substitucije aminokislin v genu za proteazo.
English: If you take more PREZISTA than you should Contact your doctor, pharmacist or nurse immediately.
Slovenian: Če ste vzeli večji odmerek zdravila PREZISTA, kot bi smeli Nemudoma pokličite svojega zdravnika, farmacevta ali medicinsko sestro.
English: Outcomes
Slovenian: Izid
English: Voriconazole should not be combined with boosted PREZISTA unless an assessment of the benefit/risk ratio justifies the use of voriconazole.
Slovenian: Vorikonazola se ne sme sočasno uporabljati z okrepljenim zdravilom PREZISTA, razen, če ocena razmerja med koristmi in tveganjem in upravičuje uporabo vorikonazola.
English: Genotypic or phenotypic testing (when available) and treatment history should guide the use of PREZISTA (see sections 4.2, 4.4 and 5.1).
Slovenian: Izvidi genotipskega in fenotipskega testiranja (če so na voljo) ter zgodovina zdravljenja morajo biti vodilo pri uporabi zdravila PREZISTA (glejte poglavja 4.2, 4.4 in 5.1).
English: PREZISTA suspension is administered orally.
Slovenian: Zdravilo PREZISTA v suspenziji se jemlje peroralno.
English: PREZISTA with ritonavir has not been tested with all PIs (protease inhibitors) and must not be used with other HIV PIs.
Slovenian: Zdravilo PREZISTA z ritonavirjem ni bilo preskušano v kombinaciji z vsemi ZP (zaviralci proteaz) in se ne sme uporabljati skupaj z drugimi zaviralci proteaz HIV.
English: PREZISTA 75 mg film-coated tablets PREZISTA 150 mg film-coated tablets PREZISTA 300 mg film-coated tablets PREZISTA 600 mg film-coated tablets
Slovenian: PREZISTA 75 mg filmsko obložene tablete PREZISTA 150 mg filmsko obložene tablete PREZISTA 300 mg filmsko obložene tablete PREZISTA 600 mg filmsko obložene tablete
English: When the recommendation is the same for PREZISTA when co-administered with a low dose ritonavir or cobicistat, the term “boosted PREZISTA” is used.
Slovenian: Če so priporočila za uporabo zdravila PREZISTA ob uporabi majhnega odmerka ritonavirja in kobicistata enaka, uporabljamo izraz “okrepljeno zdravilo PREZISTA”.
English: C-darunavir with ritonavir dose, approximately 79.5% and 13.9% of the administered dose of
Slovenian: C označenega darunavirja z ritonavirjem so v seču izmerili približno 79,5% danega odmerka darunavirja
English: If you notice within 12 hours, you must take the tablets immediately.
Slovenian: Če to opazite v 12 urah, morate vzeti tablete takoj.
English: POWER 1 and POWER 2 are randomised, controlled trials comparing PREZISTA co-administered with ritonavir (600/100 mg twice daily) with a control group receiving an investigator-selected PI(s) regimen in HIV-1 infected patients who had previously failed more than 1 PI containing regimen.
Slovenian: POWER 1 in POWER 2 sta randomizirani, nadzorovani preskušanji v katerih so zdravljenje z zdravilom PREZISTA, skupaj z ritonavirjem (600/100 mg dvakrat na dan) primerjali s kontrolno skupino, v kateri so bolniki prejemali shemo s PIji po izbiri raziskovalca, pri bolnikih, pri katerih je bil pred tem najmanj 1 režim s PI neuspešen.
English: Number of subjects with virologic failure a and phenotype data that show resistance to PIs at endpoint c, n/N
Slovenian: Število preiskovancev z virološkim neuspehom zdravljenja a in podatki o fenotipu, ki kažejo odpornost na zaviralce proteaz (PI) ob zaključku zdravljenja c, n/N
English: Uncommon side effects (may affect up to 1 in 100 people) - chest pain, changes in electrocardiogram, rapid heart beating - decreased or abnormal skin sensibility, pins and needles, attention disturbance, loss of memory,
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov) - bolečine v prsih, spremembe elektrokardiograma, hitro bitje srca - zmanjšana ali nenavadna občutljivost kože, zbadanje, motnje pozornosti, izguba spomina,
English: Interaction table Interaction studies have only been performed in adults.
Slovenian: Preglednica medsebojnih delovanj z drugimi zdravili Študije medsebojnega delovanja so bile izvedene le pri odraslih.
English: - The child must take the appropriate doses of PREZISTA and ritonavir two times per day or once a day.
Slovenian: - Predpisani odmerek zdravil PREZISTA in ritonavirja mora otrok zaužiti dvakrat na dan ali enkrat na dan.
English: The combination of boosted PREZISTA and artemether/lumefantrine can be used without dose adjustments; however, due to the increase in lumefantrine exposure, the combination should be used with caution.
Slovenian: Kombinacija okrepljenega zdravila PREZISTA in učinkovin artemeter/lumefantrin se lahko uporablja brez prilagajanja odmerkov, vendar je zaradi zvečane izpostavljenosti lumefantrinu, pri tej kombinaciji potrebna previdnost.
English: Patients received a weight-based twice daily treatment regimen, patients weighing 10 kg to < 15 kg received darunavir/ritonavir 25/3 mg/kg twice daily, and patients weighing 15 kg to < 20 kg received darunavir/ritonavir 375/50 mg twice daily.
Slovenian: Bolniki s telesno maso 10 kg do < 15 kg so prejeli darunavir/ritonavir 25/3 mg/kg dvakrat na dan, bolniki s telesno maso 15 kg do < 20 kg pa darunavir/ritonavir 375/50 mg dvakrat na dan.
English: sum of active moieties of rifabutin (parent drug + 25-O-desacetyl metabolite)
Slovenian: vsota aktivnih frakcij rifabutina (učinkovina + 25-O-deacetil presnovek)
English: ODIN is a Phase III, randomised, open-label trial comparing PREZISTA/ritonavir 800/100 mg once daily versus PREZISTA/ritonavir 600/100 mg twice daily in ART-experienced HIV-1 infected patients with screening genotype resistance testing showing no darunavir RAMs (i.e. V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V, L89V) and a screening HIV-1 RNA > 1,000 copies/ml.
Slovenian: ODIN je randomizirano, odprto preskušanje faze III, v katerem so primerjali režim PREZISTA/ritonavir 800/100 mg enkrat na dan z režimom PREZISTA/ritonavir 600/100 mg dvakrat na dan pri s HIV-1 okuženih bolnikih z izkušnjami z ART, pri katerih ob uključitvi v preskušanje testi genotipa niso pokazali nobene z rezistenco na darunavir povezane mutacije (npr.: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V, L89V) in so imeli plazemsko koncentracijo HIV-1 RNK > 1.000 kopij/ml.
English: This can be seen in a blood test. - high blood pressure, flushing - red or dry eyes - fever, swelling of lower limbs due to fluids, malaise, irritability, pain
Slovenian: To lahko pokaže krvni test. - visok krvni tlak, zardevanje - rdeče ali suhe oči - zvišana telesna temperatura, otekline spodnjih okončin zaradi tekočine, bolehnost,
English: - Tell your doctor if you have had problems with your liver before, including hepatitis B or C infection.
Slovenian: - Povejte svojemu zdravniku, če ste že kdaj imeli težave z jetri, vključno z okužbo z virusom hepatitisa B ali C. Zdravnik bo lahko ovrednotil resnost vaše jetrne bolezni, preden se odloči, ali lahko jemljete zdravilo PREZISTA.